Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Citius Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 39 | 74 | +35 |
| Shares | 11.0M | 25.2M | +14.2M (+129.8%) |
| Value | $19.3M | $87.6M | +$68.3M (+353.5%) |
New holders (44)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (9)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Sabby Management, LLC | 314,000 | $559.0K |
| Millennium Management LLC | 168,128 | $299.0K |
| Marshall Wace, LLP | 68,873 | $123.0K |
| LMR Partners LLP | 63,950 | $114.0K |
| Jane Street Group, LLC | 55,361 | $99.0K |
| Capstone Investment Advisors, LLC | 41,468 | $74.0K |
| Freed Investment Group | 14,600 | $26.0K |
| Winch Advisory Services, LLC | 1,000 | $2.00K |
| Geneos Wealth Management Inc. | 500 | $1.00K |